Qiang Liu, Ahmed Hassan, Daniele Pezzati, Basem Soliman, Laura Lomaglio, Patrick Grady, Laurent Del Angel Diaz, Andrea Simioni, Shana Maikhor, John Etterling, Giuseppe D’Amico, Giuseppe Iuppa, Teresa Diago Uso, Koji Hashimoto, Federico Aucejo, Masato Fujiki, Bijan Eghtesad, Kazunari Sasaki, Choon Hyuck David Kwon, Jacek Cywinski, Samuel Irefin, Ana Bennett, William Baldwin, Charles Miller, Cristiano Quintini – 23 October 2019 – The primary aim of this single‐center, phase 1 exploratory study was to investigate the safety, feasibility, and impact on intrahepatic hemodynamics of a fresh froze

Sanjay Kumar Yadav, Arvinder Singh Soin – 23 October 2019

Takehiro Fujii, Sergio Duarte, Eudora Lee, Bibo Ke, Ronald W. Busuttil, Ana J. Coito – 22 October 2019 – Tissue inhibitor of metalloproteinase (TIMP) 3 is a naturally occurring inhibitor of a broad range of proteases, with key roles in extracellular matrix turnover and in the pathogenesis of various diseases. In this study, we investigated the response of mice lacking TIMP3 (TIMP3−/−) to hepatic ischemia/reperfusion injury (IRI).

Faouzi Saliba, Christophe Duvoux, Sébastien Dharancy, Jérôme Dumortier, Yvon Calmus, Jean Gugenheim, Nassim Kamar, Ephrem Salamé, Martine Neau‐Cransac, Claire Vanlemmens, François Durand, Georges Pageaux, Vincent Leroy, Jean Hardwigsen, Hakam Gharbi, Cécile Masson, Malka Tindel, Filomena Conti – 21 October 2019 – The observational CERTITUDE study follows liver transplant patients who completed the SIMCER trial.

Majid M. Syed‐Abdul, Elizabeth J. Parks, Ayman H. Gaballah, Kimberlee Bingham, Ghassan M. Hammoud, George Kemble, Douglas Buckley, William McCulloch, Camila Manrique-Acevedo – 20 October 2019

Sumera Rizvi, Gregory J. Gores – 20 October 2019

Toshihiro Sugiyama – 20 October 2019

Felix Stickel, Philipp Lutz, Stephan Buch, Hans Dieter Nischalke, Ines Silva, Vanessa Rausch, Janett Fischer, Karl Heinz Weiss, Daniel Gotthardt, Jonas Rosendahl, Astrid Marot, Mona Elamly, Marcin Krawczyk, Markus Casper, Frank Lammert, Thomas W. M. Buckley, Andrew McQuillin, Ulrich Spengler, Florian Eyer, Arndt Vogel, Silke Marhenke, Johann Felden, Henning Wege, Rohini Sharma, Stephen Atkinson, Andre Franke, Sophie Nehring, Vincent Moser, Clemens Schafmayer, Laurent Spahr, Carolin Lackner, Rudolf E. Stauber, Ali Canbay, Alexander Link, Luca Valenti, Jane I. Grove, Guruprasad P.

Yoshitaka Arase, Tatehiro Kagawa – 19 October 2019

This webinar is targeted to AASLD Associate and Trainee members, as well as Junior Faculty. The goal is to provide an approach to the accurate diagnosis of Drug Induced Liver Injury (DILI), with special attention to considerations that may mask the diagnosis. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .Paul (Skip) Hayashi Dr. Hayashi is currently Co-Chair of the Causality Committee for the Drug-Induced Liver Injury Network (DILIN) and Associate Professor at the University of North Carolina (UNC), Chapel Hill, NC.